Exclusive: Cellares expands deal with Bristol Myers on CAR-T asset, eyes manufacturing expansion - Endpoints News
endpts.comSubmitted by endpointsnews6292 in business
Cellares has expanded its partnership deal with Bristol Myers Squibb to assist the Big Pharma in developing another unnamed CAR-T cell therapy via its cell therapy manufacturing platform, Cell Shuttle. The South San Francisco company also has its eyes on long…